Fulton Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
16,042
+790
+5% +$55.2K 0.04% 266
2025
Q1
$1.12M Buy
15,252
+1,315
+9% +$96.7K 0.05% 250
2024
Q4
$913K Buy
13,937
+4,608
+49% +$302K 0.04% 292
2024
Q3
$727K Buy
9,329
+211
+2% +$16.4K 0.03% 333
2024
Q2
$711K Buy
9,118
+699
+8% +$54.5K 0.03% 323
2024
Q1
$570K Sell
8,419
-669
-7% -$45.3K 0.02% 365
2023
Q4
$612K Sell
9,088
-25
-0.3% -$1.68K 0.03% 338
2023
Q3
$617K Buy
9,113
+4,903
+116% +$332K 0.03% 318
2023
Q2
$301K Buy
4,210
+1,156
+38% +$82.7K 0.01% 447
2023
Q1
$212K Buy
+3,054
New +$212K 0.01% 517
2022
Q3
Sell
-4,015
Closed -$265K 483
2022
Q2
$265K Sell
4,015
-702
-15% -$46.3K 0.01% 411
2022
Q1
$313K Sell
4,717
-149
-3% -$9.89K 0.01% 404
2021
Q4
$283K Sell
4,866
-493
-9% -$28.7K 0.01% 450
2021
Q3
$322K Buy
+5,359
New +$322K 0.02% 407
2019
Q1
Sell
-23,753
Closed -$889K 421
2018
Q4
$889K Sell
23,753
-9,402
-28% -$352K 0.07% 187
2018
Q3
$1.31M Sell
33,155
-20,751
-38% -$821K 0.09% 174
2018
Q2
$1.89M Sell
53,906
-18,193
-25% -$639K 0.13% 132
2018
Q1
$2.52M Sell
72,099
-7,567
-9% -$265K 0.18% 101
2017
Q4
$2.76M Buy
79,666
+36,750
+86% +$1.28M 0.2% 93
2017
Q3
$1.45M Buy
42,916
+6,598
+18% +$224K 0.11% 138
2017
Q2
$1.24M Sell
36,318
-1,086
-3% -$37K 0.1% 147
2017
Q1
$1.16M Buy
37,404
+11,520
+45% +$358K 0.1% 150
2016
Q4
$707K Sell
25,884
-1,023
-4% -$27.9K 0.06% 183
2016
Q3
$884K Buy
+26,907
New +$884K 0.08% 165
2015
Q1
Sell
-11,188
Closed -$394K 385
2014
Q4
$394K Sell
11,188
-1,180
-10% -$41.6K 0.04% 235
2014
Q3
$442K Sell
12,368
-528
-4% -$18.9K 0.05% 217
2014
Q2
$479K Sell
12,896
-95,946
-88% -$3.56M 0.05% 213
2014
Q1
$3.53M Sell
108,842
-4,770
-4% -$155K 0.41% 51
2013
Q4
$3.37M Sell
113,612
-49,184
-30% -$1.46M 0.4% 53
2013
Q3
$4.23M Buy
162,796
+14
+0% +$364 0.5% 43
2013
Q2
$3.85M Buy
+162,782
New +$3.85M 0.48% 47